TRDA
Entrada Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:37:37 AM EST
5.11USD+1.690%(+0.08)8,617
TRDA Financials
In Q3 FY 2026 (ended ), Entrada Therapeutics, Inc. Common Stock (TRDA) reported revenue of $905K, net income of −$39.74M, operating cash flow of −$29.96M, and assets of $266.88M (filed ).
Loading financial statements…